pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,763 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT05858489: Concordance Between Mini-Mental Stats Examination (MMSE) and an Adapted Version of the MMSE in Reunion Island Population (MMS-Run)

Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: . Conditions: Neurocognitive Deficit

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06287450: A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults

Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd. Phase: PHASE1. Conditions: Respiratory Syncytial Virus Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT07557550: Comparison of Two Relaxation Strategies Between Glasses, Virtual Reality Headset, and Without Relaxation Tool, in the Anxiety Preoperative of Orthopedic Adult Patients

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Relaxation, Virtual Reality, Anxiety Preoperative

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07438405: An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease

Sponsor: Amgen. Phase: PHASE2. Conditions: Thyroid Eye Disease

full page →ctgov ↗
›TERMINATEDphase readoutNCT00880594: Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Irritable Bowel Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07058194: Effect of Pre- and Postoperative ESP Block on Frontal QRS-T Angle in Laparoscopic Cholecystectomy

Sponsor: Harran University. Phase: NA. Conditions: Cholecystectomy, Laparoscopic, Pain, Postoperative, Electrocardiography, Regional Anesthesia, Cardiac Electrophysiology

full page →ctgov ↗
›RECRUITINGphase readoutNCT07193394: Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer

Sponsor: Institut Curie. Phase: PHASE2. Conditions: Metastatic Breast Cancer ( HER2 Negative), Unresectable Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT04728022: Brain Research Apprenticeships in New York at Columbia

Sponsor: Columbia University. Phase: NA. Conditions: Educational Activities

full page →ctgov ↗
›RECRUITINGphase readoutNCT06205953: A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: AL Amyloidosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06922045: Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

Sponsor: Jiangsu BioJeTay Biotechnology Co., Ltd.. Phase: PHASE3. Conditions: Hemophilia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06704672: Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

Sponsor: Hoffmann-La Roche. Phase: NA. Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

full page →ctgov ↗
›RECRUITINGphase readoutNCT04494672: A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System

Sponsor: Christian Candrian. Phase: NA. Conditions: Femoral Fracture

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07528872: Serum COMP and MMP-3 in Knee Osteoarthritis

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Knee Osteoarthritis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07385872: Performance of a Novel Concept for Internal Fixation of a Novel Peripheral Nerve Block Catheter

Sponsor: Nordsjaellands Hospital. Phase: NA. Conditions: Primary Condition: Nerve Block, Secondary Condition: Catheter Displacement, Focus of Study: Sciatic Nerve

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06015672: Accelerated TMS for Focal Hand Dystonia

Sponsor: Duke University. Phase: NA. Conditions: Isolated Focal Hand Dystonia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06229795: Effect of Green Tea on Obese Pediatrics With Prediabetes

Sponsor: Ain Shams University. Phase: PHASE3. Conditions: PreDiabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT07360795: Do We Really Bleed in Percutaneous Nephrolithotomy? A Single-Surgeon, Single-Center Experience

Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: . Conditions: Urolithiasis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05397639: Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

Sponsor: Suven Life Sciences Limited. Phase: PHASE3. Conditions: Agitation, Alzheimer's Type Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT04788277: Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)

Sponsor: Thomas Jefferson University. Phase: . Conditions: Prostate Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06978777: Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Brown Adipose Tissue (BAT) Physiology, Cold Exposure

full page →ctgov ↗
›COMPLETEDphase readoutNCT07317375: Effectiveness of Stanley Paris Manual Therapy vs. Conventional Physiotherapy in Reducing Pain and Improving Function in Grade II Knee Osteoarthritis

Sponsor: Ibadat International University, Islamabad. Phase: NA. Conditions: Osteoarthritis (OA) of the Knee

full page →ctgov ↗
›RECRUITINGphase readoutNCT06823375: SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

Sponsor: Chinese University of Hong Kong. Phase: PHASE2. Conditions: HCC

full page →ctgov ↗
›RECRUITINGphase readoutNCT07496957: Preserflo MicroShunt Versus Trabeculectomy

Sponsor: Medical University of Bialystok. Phase: NA. Conditions: GLAUCOMA 1, OPEN ANGLE, D (Disorder)

full page →ctgov ↗
›RECRUITINGphase readoutNCT02429557: Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

Sponsor: Vanderbilt University Medical Center. Phase: PHASE1. Conditions: Orthostatic Hypotension, Pure Autonomic Failure, Multiple System Atrophy, Autonomic Failure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07551557: Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD. Phase: PHASE1. Conditions: Hepatic Impairment and Healthy Female

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06047457: A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

Sponsor: Ipsen. Phase: PHASE3. Conditions: Episodic Migraine

full page →ctgov ↗
›RECRUITINGphase readoutNCT07444112: Effect of Myofascial Release Therapy on University Students With Text Neck Syndrome.

Sponsor: University of Health Sciences Lahore. Phase: NA. Conditions: Text Neck Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07006012: RGL-305+ Lymphoma + Exploratory Clinical Study

Sponsor: Fudan University. Phase: NA. Conditions: Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04205812: Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

Sponsor: Incyte Corporation. Phase: PHASE3. Conditions: Metastatic Squamous Non-Small Cell Lung Cancer, Metastatic Nonsquamous Non-Small Cell Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT04998812: A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy

Sponsor: Hoffmann-La Roche. Phase: PHASE4. Conditions: Multiple Sclerosis, Clinically Isolated Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT00076830: Evaluation and Treatment of Patients With Connective Tissue Disease

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Connective Tissue Disorders, Osteogenesis Imperfecta, Bone Diseases, Metabolic, Melorheostosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06920628: PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Sponsor: National Institute of Mental Health (NIMH). Phase: PHASE1. Conditions: Long COVID, Post Acute Sequelae of COVID-19

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04533919: Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Spinal Cord Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT07348419: Quadro-Iliac vs Thoracolumbar Interfascial Plane Block for Analgesia After Single-Level Lumbar Disc Surgery

Sponsor: Samsun University. Phase: NA. Conditions: Acute Pain, Spinal Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07436728: A Study of TAK-505 in Adults With Solid Tumors

Sponsor: Takeda. Phase: PHASE1. Conditions: Malignant Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT07542665: Aromatherapy vs Music Therapy for Anxiety in Children During Dental Radiography

Sponsor: Nigde Omer Halisdemir University. Phase: NA. Conditions: Dental Anxiety in Children, Pediatric Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT07408765: Physical Activity, Fatigue, Social Support, and Psychological Well-Being in Women With Primary Hypothyroidism

Sponsor: University of Oviedo. Phase: . Conditions: Hypothyroidism Primary

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06476665: A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

Sponsor: Pfizer. Phase: . Conditions: Acute Lymphocytic Leukemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07263867: Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy

Sponsor: LanZhou University. Phase: NA. Conditions: Colonoscopy, Bowel Preparation, Quality of Healthcare

full page →ctgov ↗
›COMPLETEDphase readoutNCT06914167: The Effectiveness of Lavender Aromatherapy Combined With Slow Breathing Exercises in Improving Occupational Burnout and Sleep Disorders Among Nursing Staff

Sponsor: Tri-Service General Hospital (TSGH). Phase: NA. Conditions: Sleep Wake Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT07315607: In Vivo Evaluation of the Accuracy of Immediate Screw-Retained Provisional Crowns Fabricated Using Digital Planning and Guided Surgery

Sponsor: Universidad Complutense de Madrid. Phase: NA. Conditions: Partial Edentulism, Tooth Loss / Rehabilitation

full page →ctgov ↗
›TERMINATEDphase readoutNCT05388136: Trial Comparing Different Follow-up Strategies

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Head and Neck Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05059236: A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

Sponsor: Bayer. Phase: PHASE2. Conditions: Metastatic Hormone-sensitive Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07344311: A Phase I Trial of A-CAR032 in Participants With mCRPC

Sponsor: Shanghai AbelZeta Ltd.. Phase: PHASE1. Conditions: Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05588011: Influence of Oxygenator Selection on Platelet Function and Rotational Thromboelastometry Following Cardiopulmonary Bypass

Sponsor: BRADEN DULONG. Phase: NA. Conditions: Platelet Dysfunction, Cardiopulmonary Bypass

full page →ctgov ↗
›COMPLETEDphase readoutNCT07161011: Phase 2b Controlled Study of Dosing Techniques - Part B

Sponsor: IVIEW Therapeutics Inc.. Phase: PHASE2. Conditions: Dry Eye

full page →ctgov ↗
›COMPLETEDphase readoutNCT04154111: Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Alcohol Use Disorder, Alcohol Abuse, Alcohol Dependence, Craving

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05888844: A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma

Sponsor: Incyte Corporation. Phase: PHASE2. Conditions: Cutaneous Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07324044: Chrono-ALIGN: A Chronotype-Based Chrono-Nutrition Intervention in Post-Bariatric Patients

Sponsor: King Saud University. Phase: NA. Conditions: Obesity (Disorder), Morbid Obesity, Bariatric Sleeve Gastrectomy, Meal Time, Chronotype, Circadian Rhythm

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07410234: Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy

Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Breast Cancer

full page →ctgov ↗
← prev
page 61 of 156
next →